Zimmer Biomet Holdings Total Current Assets decreased by 3.1% to $4.96B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.2%, from $5.59B to $4.96B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows relatively stable performance with a 0.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.36B | $5.31B | $4.89B | $4.52B | $4.46B | $4.53B | $4.43B | $4.41B | $4.39B | $4.37B | $4.61B | $4.63B | $4.64B | $4.86B | $4.67B | $5.59B | $5.05B | $5.83B | $5.12B | $4.96B |
| QoQ Change | — | -0.8% | -8.0% | -7.5% | -1.2% | +1.6% | -2.4% | -0.3% | -0.5% | -0.4% | +5.4% | +0.5% | +0.2% | +4.8% | -4.0% | +19.7% | -9.6% | +15.5% | -12.3% | -3.1% |
| YoY Change | — | — | — | — | -16.7% | -14.6% | -9.4% | -2.3% | -1.7% | -3.6% | +4.1% | +5.0% | +5.7% | +11.3% | +1.3% | +20.7% | +8.9% | +20.0% | +9.6% | -11.2% |